BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 2302688)

  • 1. ETS1 gene in myelodysplastic syndrome with chromosome change at 11q23.
    Ohyashiki K; Ohyashiki JH; Tauchi T; Iwabuchi H; Iwabuchi A; Toyama K
    Cancer Genet Cytogenet; 1990 Mar; 45(1):73-80. PubMed ID: 2302688
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 11q23 abnormalities in patients with acute myelogenous leukemia and myelodysplastic syndrome as detected by molecular and cytogenetic analyses.
    Ibrahim S; Estey EH; Pierce S; Glassman A; Keating M; O'Brien S; Kantarjian HM; Albitar M
    Am J Clin Pathol; 2000 Nov; 114(5):793-7. PubMed ID: 11068555
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytogenetic changes at 11q11, 11q23, and 17q11 in myelodysplastic syndrome.
    Ohyashiki K; Yoshida MA; Gibas LM; Ohyashiki JH; Katsunuma H; Ryan DH; Rowe J; Sandberg AA
    Cancer Genet Cytogenet; 1986 Apr; 21(4):287-95. PubMed ID: 3456822
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytogenetic and molecular studies of the Philadelphia translocation in myelodysplastic syndromes. Report of two cases and review of the literature.
    Verhoef G; Meeus P; Stul M; Mecucci C; Cassiman JJ; Van Den Berghe H; Boogaerts M
    Cancer Genet Cytogenet; 1992 Apr; 59(2):161-6. PubMed ID: 1581881
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Unbalanced translocation der(11)t(11;12)(q23;q13): a new recurrent cytogenetic aberration in myelodysplastic syndrome with a complex karyotype.
    Yamamoto K; Hato A; Minagawa K; Yakushijin K; Urahama N; Gomyo H; Sada A; Okamura A; Ito M; Matsui T
    Cancer Genet Cytogenet; 2004 Nov; 155(1):67-73. PubMed ID: 15527905
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytogenetic profile of myelodysplastic syndromes with complex karyotypes: an analysis using spectral karyotyping.
    Martínez-Ramírez A; Urioste M; Alvarez S; Vizmanos JL; Calasanz MJ; Cigudosa JC; Benítez J
    Cancer Genet Cytogenet; 2004 Aug; 153(1):39-47. PubMed ID: 15325092
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular cytogenetics localizes two new breakpoints on 11q23.3 and 21q11.2 in myelodysplastic syndrome with t(11;21) translocation.
    Wlodarska I; Selleri L; La Starza R; Paternotte C; Evans GA; Boogaerts M; Van den Berghe H; Mecucci C
    Genes Chromosomes Cancer; 1999 Mar; 24(3):199-206. PubMed ID: 10451699
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chromosomes in myelodysplastic syndrome: structural abnormalities of chromosome 11. Czechoslovak MDS Cooperative Group.
    Musilova J; Michalova K; Jarosova M
    Ann Genet; 1989; 32(1):43-6. PubMed ID: 2751248
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DNA fragments of altered electrophoretic mobility in leukemia samples can arise from double-strand DNA breaks at nuclease hypersensitive sites of active genes.
    Miesfeldt S; Kim S; Hanson CA; Bohjanen PR; Leiden JM; Crist WM; Carroll AJ; Thompson CB
    Cancer Genet Cytogenet; 1993 Jul; 68(1):34-41. PubMed ID: 8330281
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular cytogenetic analysis discloses complex genetic imbalance in a t(11;21) myelodysplastic syndrome.
    Kerim S; Rege-Cambrin G; Guerrasio A; Rosso C; Van Den Berghe H
    Cancer Genet Cytogenet; 1990 Jun; 46(2):243-50. PubMed ID: 2187596
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Two myelodysplastic syndrome cases with the inv(11)(p15q23) as a sole chromosomal abnormality.
    Mitani K; Sato Y; Hayashi Y; Miura Y; Miyagawa K; Yazaki Y; Hirai H
    Br J Haematol; 1992 Aug; 81(4):512-5. PubMed ID: 1390237
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Myelodysplastic syndromes associated with 11q23 abnormalities. European 11q23 Workshop participants.
    Bain BJ; Moorman AV; Johansson B; Mehta AB; Secker-Walker LM
    Leukemia; 1998 May; 12(5):834-9. PubMed ID: 9593289
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Further localization of ETS1 indicates that the chromosomal rearrangement in Ewing sarcoma does not occur at fra(11)(q23).
    Simmers RN; Sutherland GR
    Hum Genet; 1988 Feb; 78(2):144-7. PubMed ID: 3422214
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chromosome abnormalities in the myelodysplastic syndromes.
    Heim S; Mitelman F
    Clin Haematol; 1986 Nov; 15(4):1003-21. PubMed ID: 3552345
    [No Abstract]   [Full Text] [Related]  

  • 15. Refractory thrombocytopenia with chromosome 11q23 abnormality.
    Imoto S; Hayashi Y; Matsui T; Murayama T; Iwata N; Matsuoka H; Nagata A; Itoh H; Chihara K
    Ann Hematol; 1996 Aug; 73(2):99-102. PubMed ID: 8774620
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peripheral blood chromosome aberrations in MDS.
    White AD; Jacobs A
    Cancer Genet Cytogenet; 1992 Apr; 59(2):167-72. PubMed ID: 1581882
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytogenetic evolution following the transformation of myelodysplastic syndrome to acute myelogenous leukemia: implications on the overlap between the two diseases.
    Ghaddar HM; Stass SA; Pierce S; Estey EH
    Leukemia; 1994 Oct; 8(10):1649-53. PubMed ID: 7934160
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Translocation t(6;9)(p22.3;q34) in myelodysplastic syndrome--refractory anemia with excess blasts.
    Fan YS; Raza A; Schumer J; Sait SN; Block AW; Snyderman M; Sandberg AA
    Cancer Genet Cytogenet; 1987 Nov; 29(1):135-8. PubMed ID: 3664444
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Myelodysplastic syndrome with a t(2;11)(p21;q23-24) and translocation breakpoint close to miR-125b-1.
    Thorsen J; Aamot HV; Roberto R; Tjønnfjord GE; Micci F; Heim S
    Cancer Genet; 2012 Oct; 205(10):528-32. PubMed ID: 22944560
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantifying chromosome changes and lineage involvement in myelodysplastic syndrome (MDS) using fluorescent in situ hybridization (FISH).
    Han K; Lee W; Harris CP; Kim W; Shim S; Meisner LF
    Leukemia; 1994 Jan; 8(1):81-6. PubMed ID: 8289503
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.